U.S. flag

An official website of the United States government

nsv3871139

  • Variant Calls:3
  • Validation:Not tested
  • Clinical Assertions: Yes
  • Region Size:52

Genome View

Select assembly:
Overlapping variant regions from other studies: 95 SVs from 21 studies. See in: genome view    
Submitted genomic12,943,751-12,943,802Question Mark
Overlapping variant regions from other studies: 95 SVs from 21 studies. See in: genome view    
Submitted genomic13,054,565-13,054,616Question Mark

Variant Region Placement Information

Variant Region IDPlacement TypeAssemblyAssembly UnitSequence IDChrStartStop
nsv3871139Submitted genomicGRCh38 (hg38)Primary AssemblyNC_000019.10Chr1912,943,75112,943,802
nsv3871139Submitted genomicGRCh37 (hg19)Primary AssemblyNC_000019.9Chr1913,054,56513,054,616

Variant Call Information

Variant Call IDTypeMethodAnalysisSubject PhenotypeClinical InterpretationSource of InterpretationClinVar ID
nssv15161057deletionMultipleMultipleEssential thrombocythemia; See individual phenotypes in OMIM allelic variants; THROMBOCYTHEMIA 1; THCYT1PathogenicClinVarRCV000083257.5, VCV000097006.2
nssv15161303deletionMultipleMultipleMYELOFIBROSIS; Myelofibrosis; Primary Myelofibrosis; Primary myelofibrosisPathogenicClinVarRCV000083256.5, VCV000097006.2
nssv18329416deletionMultipleMultipleEssential thrombocythemia; MYELOFIBROSIS; Myelofibrosis; Primary Myelofibrosis; Primary myelofibrosis; See individual phenotypes in OMIM allelic variants; THROMBOCYTHEMIA 1; THCYT1PathogenicClinVarRCV002498437.1, VCV000097006.2

Variant Call Placement Information

Variant Call IDPlacement TypeHGVSAssemblySequence IDChrStartStop
nssv15161057Submitted genomicNC_000019.10:g.129
43751_12943802del
GRCh38 (hg38)NC_000019.10Chr1912,943,75112,943,802
nssv15161303Submitted genomicNC_000019.10:g.129
43751_12943802del
GRCh38 (hg38)NC_000019.10Chr1912,943,75112,943,802
nssv18329416Submitted genomicNC_000019.10:g.129
43751_12943802del
GRCh38 (hg38)NC_000019.10Chr1912,943,75112,943,802
nssv15161057Submitted genomicNC_000019.9:g.1305
4565_13054616del
GRCh37 (hg19)NC_000019.9Chr1913,054,56513,054,616
nssv15161303Submitted genomicNC_000019.9:g.1305
4565_13054616del
GRCh37 (hg19)NC_000019.9Chr1913,054,56513,054,616
nssv18329416Submitted genomicNC_000019.9:g.1305
4565_13054616del
GRCh37 (hg19)NC_000019.9Chr1913,054,56513,054,616

No validation data were submitted for this variant

Clinical Assertions

Variant Call IDHGVSTypeAllele OriginSubject PhenotypeClinical InterpretationSource of InterpretationClinVar ID
nssv15161057GRCh37: NC_000019.9:g.13054565_13054616del, GRCh38: NC_000019.10:g.12943751_12943802deldeletionsomaticEssential thrombocythemia; See individual phenotypes in OMIM allelic variants; THROMBOCYTHEMIA 1; THCYT1PathogenicClinVarRCV000083257.5, VCV000097006.2
nssv15161303GRCh37: NC_000019.9:g.13054565_13054616del, GRCh38: NC_000019.10:g.12943751_12943802deldeletionsomaticMYELOFIBROSIS; Myelofibrosis; Primary Myelofibrosis; Primary myelofibrosisPathogenicClinVarRCV000083256.5, VCV000097006.2
nssv18329416GRCh37: NC_000019.9:g.13054565_13054616del, GRCh38: NC_000019.10:g.12943751_12943802deldeletionunknownEssential thrombocythemia; MYELOFIBROSIS; Myelofibrosis; Primary Myelofibrosis; Primary myelofibrosis; See individual phenotypes in OMIM allelic variants; THROMBOCYTHEMIA 1; THCYT1PathogenicClinVarRCV002498437.1, VCV000097006.2

No genotype data were submitted for this variant

Support Center